Monometacrine (INNTooltip International Nonproprietary Name; developmental code name SD-735), also known as desmethyldimetacrine, is a drug of the tricyclic family described as an antidepressant which was never marketed.[1][2][3] It was first described in the literature by 1966.[1] The drug is the N-desmethyl analogue of dimetacrine and is a metabolite of dimetacrine.[1][3]

References

  1. ^ a b c Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 835. ISBN 978-1-4757-2085-3. Retrieved 20 October 2024.
  2. ^ Negwer M, Scharnow HG (2001). Organic-chemical Drugs and Their Synonyms: An International Survey. Wiley-VCH. p. 1788. ISBN 978-3-527-30247-5. Retrieved 20 October 2024.
  3. ^ a b "Monometacrine". Inxight Drugs. National Center for Advancing Translational Sciences (NCATS). Retrieved 20 October 2024.


No tags for this post.